GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 5,130 | 3,470 | 3,040 | 2,770 | 2,650 |
| Cost of Goods | 2,930 | 2,070 | 1,330 | 1,280 | 970 |
| Gross Profit | 2,043 | 1,400 | 1,710 | 1,490 | 1,680 |
| Operating Expenses | 930 | 70 | 330 | 280 | 970 |
| Operating Income | 2,200 | 1,400 | 1,710 | 1,490 | 1,680 |
| Interest Expense | 170 | 40 | 0 | 0 | 0 |
| Other Income | -10,922 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -8,892 | 1,360 | 1,710 | 1,490 | 1,680 |
| Net Income Continuous | -8,892 | 1,360 | 1,710 | 1,490 | 1,680 |
| Net Income | $-8,890 | $-5,560 | $-1,480 | $-330 | $-190 |
| EPS Basic Total Ops | -5,166,976.00 | -4,327,330.00 | -1,913,265.00 | -12,811,590.00 | -7,376,347.00 |
| EPS Basic Continuous Ops | -5,168,139.00 | 1,058,484.00 | 2,210,597.00 | 57,846,270.00 | 65,222,440.00 |
| EBITDA(a) | $3,560 | $1,950 | $1,760 | $1,530 | $1,700 |